GLYTHERA LTD has a total of 18 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2009. It filed its patents most often in EPO (European Patent Office), Hong Kong and China. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are AMPLYX PHARMACEUTICALS INC, EUCLISES PHARMACEUTICALS INC and ZAK & LSTROK ADY FARMACEUTYCZN.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 4 | |
#2 | Hong Kong | 3 | |
#3 | China | 2 | |
#4 | United Kingdom | 2 | |
#5 | Japan | 2 | |
#6 | United States | 2 | |
#7 | Israel | 1 | |
#8 | Republic of Korea | 1 | |
#9 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Peptides | |
#4 | Heterocyclic compounds | |
#5 | Sugars |
# | Name | Total Patents |
---|---|---|
#1 | Watts Andrew Graham | 8 |
#2 | Kantner Terrence | 8 |
#3 | Mackenzie Amanda Barbara | 6 |
#4 | Birchall Christopher Michael | 6 |
#5 | Thirlway Jenny | 6 |
#6 | Baxter Anthony David | 6 |
#7 | Mansell David James | 6 |
#8 | Mysliwy Justyna Helena | 6 |
#9 | Amanda Barbara Mackenzie | 2 |
#10 | Mackenzie Amanda | 2 |
Publication | Filing date | Title |
---|---|---|
GB201419108D0 | Materials and methods relating to linkers for use in antibody drug conjugates |